1. BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets U.S. Approvals, 2002-present;Biopharma,2017
2. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection;Jin;Patient Prefer Adherence,2015
3. Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom;Rule;J Med Econ,2014
4. Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer;Sanford;Target Oncol,2014
5. Intravenous versus subcutaneous dosing of epoetin: a review of the literature;Ashai;Am J Kidney Dis,1993